Published in
Elsevier, Leukemia Research, (50), p. 123-131, 2016
DOI: 10.1016/j.leukres.2016.09.012
Links
Tools
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study
Journal article published in 2016 by
Ronan T. Swords,
Peter L. Greenberg,
Andrew H. Wei 
,
Simon Durrant,
Anjali S. Advani,
Mark S. Hertzberg,
Ian D. Lewis,
Gabriel Rivera,
Dita Gratzinger,
Alice C. Fan,
Dean W. Felsher,
Geoff T. Yarranton,
Jorge E. Cortes,
Justin M. Watts,
Jackie M. Walling
and other authors.
,
Simon Durrant,
Anjali S. Advani,
Mark S. Hertzberg,
Ian D. Lewis,
Gabriel Rivera,
Dita Gratzinger,
Alice C. Fan,
Dean W. Felsher,
Geoff T. Yarranton,
Jorge E. Cortes,
Justin M. Watts,
Jackie M. Walling
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 